Overview

Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty

Status:
Completed
Trial end date:
2018-02-28
Target enrollment:
0
Participant gender:
All
Summary
This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use on an as needed basis. The third arm will comprise a multimodal pain management protocol, which does not routinely allow for opioid consumption. However, patients will be provided a one week supply of oxycodone and tramadol for emergency pain relief only.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Rothman Institute Orthopaedics
Treatments:
Analgesics, Opioid
Criteria
Inclusion Criteria:

- Patients undergoing unilateral, primary cementless THA with underlying diagnosis of
osteoarthritis.

- ASA I - III

- Spinal anesthesia

- Male and Female over 18 who are willing and able to provide informed consent

Exclusion Criteria:

- Opioid use within 3 months prior to surgery

- General anesthesia

- Non-english speaking

- ASA IV or greater

- Allergy/contraindications to protocol medications

- Renal insufficiency with Cr > 2.0 or hepatic failure

- Sensory/motor disorder involving the operative limb

- Planned or unplanned discharge to rehab

- Length of stay >3 days

- Revision or conversion THA

- Cigarette smokers